Raanana, Israel

Yehezkel Bremer


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yehezkel Bremer: Innovator in Immune Barrier Technology

Introduction

Yehezkel Bremer is a notable inventor based in Raanana, Israel. He has made significant contributions to the field of biomedical engineering, particularly in the development of immune barrier technologies. With a total of 3 patents to his name, Bremer continues to push the boundaries of innovation in his field.

Latest Patents

One of Bremer's latest patents is focused on a multiple-layer immune barrier for donor cells. This innovative system includes a plurality of donor cells encapsulated within a first alginate structure. The first alginate structure has a guluronic acid concentration ranging from 64% to 74%. Surrounding this first structure is a second alginate structure, which contains a mannuronic acid concentration between 52% and 60%. Additionally, a selectively-permeable membrane is coupled at least in part to the second alginate structure, enhancing the functionality of the system. Other embodiments of this technology are also described in his patent.

Career Highlights

Bremer is currently associated with Beta-O2 Technologies Ltd., where he applies his expertise in developing advanced biomedical solutions. His work has garnered attention for its potential to improve transplant outcomes and enhance the viability of donor cells.

Collaborations

Throughout his career, Bremer has collaborated with notable professionals in the field, including Uriel Barkai and Avi Rotem. These collaborations have contributed to the advancement of his innovative projects and patents.

Conclusion

Yehezkel Bremer stands out as a key figure in the realm of immune barrier technology. His innovative patents and collaborations reflect his commitment to advancing biomedical engineering. His work continues to inspire future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…